RxDoctor Payments Data

Amy Cox

Family · Georgetown, KYNPI 1942516315

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,374 and has fallen 96.1% since, to $54 in 2025.

$1,595in general payments, 2019–2025

Across 97 payments — averaging $16.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$234
  • Novo Nordisk$143
  • Boehringer Ingelheim$115
  • GSK$98
  • Takeda Pharmaceuticals U.S.A., Inc.$97
  • Pfizer$93
  • plus $817 from 18 others

What the payments were for

  • Food & beverage$1,595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,595 in reported general payments places this provider in the 75th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky →

Other family in Georgetown

See the full list for Kentucky →

Where these figures come from

Is this you, or does something look wrong? →